OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Back to the Future: Esmethadone, the (Maybe) Nonopiate Opiate, and Depression
Charles B. Nemeroff
American Journal of Psychiatry (2022) Vol. 179, Iss. 2, pp. 83-84
Closed Access | Times Cited: 9
Charles B. Nemeroff
American Journal of Psychiatry (2022) Vol. 179, Iss. 2, pp. 83-84
Closed Access | Times Cited: 9
Showing 9 citing articles:
Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges
Michael J. Lucido, Boadie W. Dunlop
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 161-161
Open Access | Times Cited: 2
Michael J. Lucido, Boadie W. Dunlop
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 161-161
Open Access | Times Cited: 2
The opioid system in depression
Luke A. Jelen, James Stone, Allan H. Young, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104800-104800
Open Access | Times Cited: 53
Luke A. Jelen, James Stone, Allan H. Young, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104800-104800
Open Access | Times Cited: 53
Clinical specificity profile for novel rapid acting antidepressant drugs
Mauro Scala, Giuseppe Fanelli, Diana De Ronchi, et al.
International Clinical Psychopharmacology (2023) Vol. 38, Iss. 5, pp. 297-328
Open Access | Times Cited: 26
Mauro Scala, Giuseppe Fanelli, Diana De Ronchi, et al.
International Clinical Psychopharmacology (2023) Vol. 38, Iss. 5, pp. 297-328
Open Access | Times Cited: 26
Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression
Courtney M. Vecera, Alan C. Courtes, Gregory Jones, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1572-1572
Open Access | Times Cited: 15
Courtney M. Vecera, Alan C. Courtes, Gregory Jones, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1572-1572
Open Access | Times Cited: 15
Understanding the Efficacy and Mechanism of Action of a Dextromethorphan-Bupropion Combination: Where Does It Fit in the NMDA Versus mu-Opioid Story?
Alan F. Schatzberg
American Journal of Psychiatry (2022) Vol. 179, Iss. 7, pp. 448-450
Closed Access | Times Cited: 17
Alan F. Schatzberg
American Journal of Psychiatry (2022) Vol. 179, Iss. 7, pp. 448-450
Closed Access | Times Cited: 17
A Critical View on New and Future Antidepressants
Alessandro Serretti
Clinical Psychopharmacology and Neuroscience (2024) Vol. 22, Iss. 2, pp. 201-210
Open Access | Times Cited: 2
Alessandro Serretti
Clinical Psychopharmacology and Neuroscience (2024) Vol. 22, Iss. 2, pp. 201-210
Open Access | Times Cited: 2
The why, when, where, how, and so what of so-called rapidly acting antidepressants
Alan F. Schatzberg, Sanjay J. Mathew
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 189-196
Closed Access | Times Cited: 4
Alan F. Schatzberg, Sanjay J. Mathew
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 189-196
Closed Access | Times Cited: 4
Unipolar depression
Charles F. Gillespie, Charles B. Nemeroff
Elsevier eBooks (2024), pp. 881-901
Closed Access
Charles F. Gillespie, Charles B. Nemeroff
Elsevier eBooks (2024), pp. 881-901
Closed Access
Spanning Treatment Modalities: Psychotherapy, Psychopharmacology, and Neuromodulation
Ned H. Kalin
American Journal of Psychiatry (2022) Vol. 179, Iss. 2, pp. 75-78
Closed Access | Times Cited: 1
Ned H. Kalin
American Journal of Psychiatry (2022) Vol. 179, Iss. 2, pp. 75-78
Closed Access | Times Cited: 1
